Evidence map›Paper›PMID 39852697›Full record

ArticleNanomaterials (Basel, Switzerland)2025

Designing and Fabrication of Nano-Hydroxyapatite and Curcumin-Loaded Chitosan/PVA Nanofibrous Mats for Potential Use as Wound Dressing Biomaterials.

Amira M El-Rafei, Giorgia Maurizii, Annalisa Aluigi, Giovanna Sotgiu, Marianna Barbalinardo, Tamara Posati

Abstract read
In one paragraph

Article in Nanomaterials (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Amira M El-RafeiRefractories, Ceramics and Building Materials Department, National Research Centre, 33 EL Bohouth St., Dokki, Giza P.O. Box 12622, Egypt.
Giorgia MauriziiDepartment of Biomolecular Sciences, University of Urbino Carlo Bo, Piazza del Rinascimento, 6, 61029 Urbino, Italy.
Annalisa AluigiDepartment of Biomolecular Sciences, University of Urbino Carlo Bo, Piazza del Rinascimento, 6, 61029 Urbino, Italy.
Giovanna SotgiuConsiglio Nazionale delle Ricerche (CNR), Istituto per la Sintesi Organica e Fotoreattività (ISOF), Via Piero Gobetti, 101, 40129 Bologna, Italy.ORCID 0000-0003-3590-714X
Marianna BarbalinardoConsiglio Nazionale delle Ricerche (CNR), Istituto per la Sintesi Organica e Fotoreattività (ISOF), Via Piero Gobetti, 101, 40129 Bologna, Italy.ORCID 0000-0002-2143-2860
Tamara PosatiConsiglio Nazionale delle Ricerche (CNR), Istituto per la Sintesi Organica e Fotoreattività (ISOF), Via Piero Gobetti, 101, 40129 Bologna, Italy.ORCID 0000-0002-3879-266X

Funding

Academy of Scientific Research and Technology 9672
6 · The paper itself

Abstract

Chitosan/polyvinyl alcohol nanofibrous mats loaded with nano-hydroxyapatite and/or curcumin are successfully fabricated by the electrospinning method for the first time. Nano-hydroxyapatite is prepared by the co-precipitation method. The XRD pattern of calcined powder at 700 °C for 2 h reveals the presence of hydroxyapatite as a sole phase. FT-IR confirms its purity. The morphology of the hydroxyapatite is studied by HR-TEM. Nano-hydroxyapatite and curcumin are added at 5 wt% with respect to the polymer weight. XRD, FE-SEM, FT-IR, and HR-TEM are used to characterize the fabricated nanofibrous mats. The results confirm the successful loading of nano-hydroxyapatite and curcumin within the fabricated mats. The in vitro antimicrobial results show that most of mats have significant antimicrobial effects against

Indexed as

chitosancurcumindrug deliveryelectrospinningnano-hydroxyapatitepolyvinyl alcohol

Identifiers

PMID39852697
PMCPMC11767821

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.